In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...
Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...
DNA Synthesis Market to Reach $30.4 billion, Globally, by 2035 at 18.2% CAGR: Allied Market Research
DNA synthesis technologies, supported by automated synthesizers, high-throughput platforms, oligonucleotide production ...
I distinctly remember the day I first learned about using plasmids to manipulate bacteria during my undergraduate studies in microbiology. The experiment was quite simple, but at the time, I was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results